Compare VET & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VET | WGS |
|---|---|---|
| Founded | 1994 | 2017 |
| Country | Canada | United States |
| Employees | N/A | 1300 |
| Industry | Oil & Gas Production | Retail: Computer Software & Peripheral Equipment |
| Sector | Energy | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | 2004 | N/A |
| Metric | VET | WGS |
|---|---|---|
| Price | $12.44 | $58.80 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | $15.00 | ★ $130.71 |
| AVG Volume (30 Days) | ★ 3.1M | 661.5K |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | ★ 3.07% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $11.01 | $29.98 |
| Revenue Next Year | $3.02 | $25.92 |
| P/E Ratio | ★ N/A | $1,251.58 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.90 | $55.17 |
| 52 Week High | $14.82 | $170.87 |
| Indicator | VET | WGS |
|---|---|---|
| Relative Strength Index (RSI) | 48.22 | 33.00 |
| Support Level | $7.42 | $55.18 |
| Resistance Level | $14.55 | $95.75 |
| Average True Range (ATR) | 0.61 | 4.26 |
| MACD | -0.21 | 0.25 |
| Stochastic Oscillator | 7.11 | 16.20 |
Vermilion Energy Inc is an international oil and gas-producing company. The company engages in full-cycle exploration and production programs that focus on the acquisition, exploration, and development of liquids-rich natural gas in Canada and conventional natural gas in Europe while optimizing low-decline oil assets. Its operating segments are: Canada, France, Netherlands, Germany, Ireland, Australia, and CEE, each representing the oil and gas exploration operations at its assets located in these regions. The company mainly derives revenue from the production and sale of petroleum and natural gas. The majority of its revenue is generated from Canada, where the company's operations are mainly focused on the Deep Basin trend in the West Pembina region of Alberta and on the Mica property.
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.